Spectral Medical Inc.
EDT.TO
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 25.18% | 6.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.18% | 6.94% | |||
| Cost of Revenue | -18.39% | -15.44% | |||
| Gross Profit | 106.55% | 111.37% | |||
| SG&A Expenses | -7.85% | -26.28% | |||
| Depreciation & Amortization | -8.53% | -88.31% | |||
| Other Operating Expenses | -76.07% | -- | |||
| Total Operating Expenses | -12.04% | -29.02% | |||
| Operating Income | 18.30% | 32.82% | |||
| Income Before Tax | 130.79% | -127.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 130.79% | -127.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 130.75% | -127.80% | |||
| EBIT | 18.30% | 32.82% | |||
| EBITDA | 18.38% | 33.05% | |||
| EPS Basic | 130.38% | -126.09% | |||
| Normalized Basic EPS | 130.67% | -126.39% | |||
| EPS Diluted | 130.38% | -126.09% | |||
| Normalized Diluted EPS | 130.67% | -126.39% | |||
| Average Basic Shares Outstanding | 0.64% | 0.59% | |||
| Average Diluted Shares Outstanding | 0.64% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||